Helen Maclean is a Speech and Language Therapist with extensive experience in working with adults with acquired neurological disorders. She has an undergraduate degree in Psychology and Biology, a Masters degree in Psychology, and a Postgraduate Diploma in Speech and Language Therapy.

Since qualifying as an SLT in 2010, Helen has worked in a range of healthcare settings. She has a passion for working with those who have communication difficulties following brain injury, stroke, and other neurological conditions. She has extensive clinical knowledge and experience of eating, drinking, and swallowing disorders; having assessed and supported individuals in settings such as acute hospital wards, outpatient appointments, care homes, and individual’s own homes.

This passion extends beyond working directly with individuals and their families. This shows itself in being a co-host of The Brainy Speech Therapist Podcast, being Vice-Chair of Headway South Lanarkshire, and co-authoring the Royal College of Speech and Language Therapy’s Clinical Guidelines on Cognitive Communication Disorders (to be published in 2026). (See Resources for links)

Helen spent 14 years as an NHS Speech and Language Therapist, before moving into private practice with Speech Therapy Glasgow in 2024. She has now founded her own company with Neuro Speech Therapy, as well as working for the Active Care Group at Murdostoun Brain Injury Rehabilitation and Neurological Care Centre.

Academic qualifications

BSc (Hons) Psychology and Biology, University of Paisley, 2004

MEd Psychological Studies, University of Glasgow, 2005

PGDip Speech and Language Therapy, Queen Margaret University, 2010

Post-graduate training

In addition to the degrees listed above, Helen has undertaken post-graduate training in dysphagia, and is certified in Talking Mats, LSVT LOUD, and Speak Out!

Memberships

HCPC registration number SL29218

CertMRCSLT registration number RC0029544

ASLTIP registration number 4658

Helen is also a member of the British Aphasiology Society, United Kingdom Acquired Brain Injury Forum (UKABIF), and the Parkinson’s UK SLT Clinical Excellence Network.